Intelligent Blood Treatment Apparatus with Real-time Optimization

An advanced blood treatment system integrating artificial intelligence, real-time monitoring, and personalized treatment protocols to revolutionize patient care and treatment outcomes.

The original patent addressed the need for efficient blood treatment by providing a method for setting a control device or a closed-loop control device of a blood treatment apparatus. However, the original invention has limitations in terms of static treatment protocols, lack of real-time monitoring, and limited adaptability to individual patient needs. The new inventive concept tackles these limitations by introducing a self-adjusting blood pump, artificial intelligence module, and real-time monitoring capabilities to optimize treatment outcomes.

The new inventive concept comprises a blood treatment apparatus with a self-adjusting blood pump, which dynamically adjusts blood flow rates based on real-time analysis of patient vital signs and treatment efficacy. The apparatus also features an artificial intelligence module that optimizes treatment protocols using machine learning algorithms and historical treatment data. Additionally, the system includes a sensor module for continuous monitoring of patient vital signs and treatment efficacy, enabling real-time adjustments to treatment parameters. The wearable device for real-time monitoring of patient vital signs during blood treatment further enhances the system's capabilities.

The new claims introduce a paradigm shift in blood treatment by incorporating artificial intelligence, real-time monitoring, and personalized treatment protocols, which are not anticipated by the original patent. The self-adjusting blood pump, artificial intelligence module, and wearable device for real-time monitoring are novel and non-obvious features that provide a significant improvement over the existing technology.

Alternative embodiments of the inventive concept could include different types of sensors, various machine learning algorithms, or alternative communication protocols for the wearable device. Additionally, the system could be adapted for use in different medical settings, such as hospitals or clinics, or integrated with other medical devices to create a comprehensive treatment platform.

The intelligent blood treatment apparatus has significant commercial potential in the medical device industry, particularly in the fields of nephrology and hemodialysis. The system's ability to optimize treatment outcomes and improve patient care could lead to increased adoption in hospitals and clinics, as well as in home healthcare settings.